Johnson & Johnson (NYSE: JNJ) released its fiscal second-quarter earnings report before the markets opened on Tuesday. The company posted $1.83 in earnings per share (EPS) on $18.8 billion in revenue. The…
Chris Lange 24/7 Wall St. has put together a preview of General Electric, Microsoft and other Dow Jones Industrial Average companies scheduled to report their quarterly results this coming week.
Johnson & Johnson and Merck were the top performers among the Dow 30 stocks Thursday while Goldman Sachs and Wal-Mart were the big laggards.
These are the top 20 stock buybacks in dollars spent during the first quarter of 2017 of all S&P 500 companies.
With a Federal Reserve rate hike decision, investors have to keep in mind what to think of the stock market heading into the rest of this summer and what to expect for…
Boeing, 3M, Johnson & Johnson, and Visa all posted new 52-week highs Friday to lead the DJIA's gain for the day.
When companies see their shares rise almost 50%, investors probably just assume the news is from a buyout or a merger. In Tuesday's massive gain in shares of Protagonist Therapeutics, it was…
Jon C. Ogg Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech.
Chris Lange The DJIA is trading narrowly lower just minutes before Friday's closing bell. Home Depot and J&J are leading the losers, while Disney and Nike are the leading gainers.
If Warren Buffett is considered the greatest investor of the modern era, and if he has held the title of the world's richest man, then maybe he knows a thing or two.
J&J, Cisco, Caterpillar, and Goldman Sachs led the Dow Industrials higher on Monday.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Cerner, Cisco Systems, Johnson & Johnson, Level 3 Communications and Salesforce.com.
As the summer approaches, many investors fear that a stock market correction could come at almost any time. Here are the eight most attractive defensive stocks for investors seek refuge in for…
Goldman Sachs, J&J, American Express, and Travelers were the worst performing DJIA stocks on Tuesday.
Health care giant Johnson & Johnson missed sales estimates but beat analysts' profit target. The $30 billion acquisition of Actelion has been included in revised guidance for the 2017 fiscal year.
Paul Ausick 